For this, to further check the role of mutant p53 in migration of NSCLCs, oncogenic K-ras expressing mutant p53 bearing NSCLC cell line NCI-H522 was used for wound healing migration assay (Additional file 1: Figure S1). Here, KRAS is linked to non-small cell lung carcinoma.